{
    "nctId": "NCT00627276",
    "briefTitle": "Omega-3 Fatty Acids in Treating Women With Newly Diagnosed Ductal Carcinoma In Situ and/or Atypical Ductal Hyperplasia",
    "officialTitle": "Omega-3 Fatty Acids and Prevention of DCIS and/or ADH: A Translational Approach",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer, Precancerous Condition",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 16,
    "primaryOutcomeMeasure": "Effect of omega-3 fatty acids on markers of breast cancer progression",
    "eligibilityCriteria": "DISEASE CHARACTERISTICS:\n\n* Biopsy confirmed diagnosis of any of the following:\n\n  * Ductal carcinoma in situ (DCIS) and/or atypical ductal hyperplasia (ADH)\n  * DCIS with a component of invasive carcinoma\n  * ADH with a component of invasive carcinoma\n  * DCIS and ADH with a component of invasive carcinoma\n* Newly diagnosed disease\n* No pure invasive breast cancer on biopsy without a component of DCIS or ADH\n* Hormone receptor status not specified\n\nPATIENT CHARACTERISTICS:\n\n* Female\n* Menopausal status not specified\n* Not pregnant\n* Negative pregnancy test\n* Speaks English or Spanish\n* No allergy to fish oil or olive oil\n* No condition that, in the opinion of the study clinician, would make participation in the study harmful to the patient\n\nPRIOR CONCURRENT THERAPY:\n\n* No concurrent therapeutic anticoagulation\n* No concurrent use of fish oil \\> 1 g/day",
    "sex": "FEMALE",
    "minimumAge": "21 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}